| Autor: |
Husereau D; adjunct professor, senior associate, School of Epidemiology and Public Health, University of Ottawa, Ontario, Canada. Institute of Health Economics, Alberta, Canada., Drummond M; Michael Drummond, professor, Centre for Health Economics, University of York, York, UK., Augustovski F; director, professor of public health, principal researcher, Health Technology Assessment and Health Economics Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, University of Buenos Aires, Buenos Aires, CONICET (National Scientific and Technical Research Council), Buenos Aires, Argentina., de Bekker-Grob E; full professor of health economics & health preferences, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Briggs AH; professor of health economics, London School of Hygiene and Tropical Medicine, London, England, UK., Carswell C; senior editor, Adis Journals, Springer Nature, Auckland, New Zealand., Caulley L; assistant professor, associate scientist, doctoral candidate, Department of Otolaryngology - Head & Neck Surgery, University of Ottawa, Ontario, Canada. Clinical Epidemiology Program and Center for Journalology, Ottawa Hospital Research Institute, Ontario, Canada. Department of Epidemiology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Chaiyakunapruk N; professor, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA., Greenberg D; professor, Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel., Loder E; professor, head of research, Harvard Medical School, Boston, MA, USA; The BMJ, London, UK., Mauskopf J; vice president, RTI Health Solutions, RTI International, Research Triangle Park, NC, USA., Mullins CD; professor and chair, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA., Petrou S; professor of health economics, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Pwu RF; National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei City, Taiwan., Staniszewska S; professor of health research, on behalf of CHEERS 2022 ISPOR Good Research Practices Task Force. Warwick Research in Nursing, University of Warwick Warwick Medical School, Warwick, UK. |
| Abstrakt: |
Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making. |
